Cinchona Officinalis Pellet
Product Images NDC 15631-0138

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cinchona Officinalis (NDC 15631-0138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0138

This appears to be a description of a homeopathic medicine, primarily composed of Sucrose with Cinchona Officinalis 2X as the active ingredient. It is used for temporary relief of upset stomach and can be taken orally by adults and children. The dosage and other instructions are given on the label. The medicine should be kept in a cool, dark place, and the cap should be tightly closed after use. The product has a shelf life and should be used before the expiration date.*

FDA Label Image

Mini Labels Pellets Fda15631 0138

This is a description of a homeopathic medicine that is used for temporary relief of upset stomach. The active ingredient is Cinchona Officinalis 2X and the inactive ingredient is sucrose. It comes in the form of pellets and is taken orally. The dosage for adults is four pellets three times a day, while children are advised to take half the adult dose. The medicine is not accepted by medical professionals and is not FDA regulated. The label comes in a blister pack for select pack sizes. The NDC number is 15631-0138 and the batch number, manufacturing date, and expiration date are provided.*

FDA Label Image

Rxhomeo Secondary Packing Blister Pack

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

This is a label for a single, lactose-free homeopathic remedy manufactured by Rihomeo Private Limited according to the Homoeopathic Pharmacopoeia of the United States (HPUS). It includes warnings to discontinue use if symptoms worsen or do not improve after four days and seek medical advice if the user is pregnant, breastfeeding, or taking medication. The label also contains distribution information for Rehomeo, Inc and information related to packing and distribution.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.